CL / Colgate-Palmolive Recalls Millions of Bottles of Fabuloso Over Bacteria Risk

Colgate-Palmolive (CL) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CL broke th more_horizontal

Colgate-Palmolive (NYSE: CL) recently reported its Q3 results, with revenues and earnings beating the street estimates. more_horizontal

Earnings season continues to chug along, picking up notable steam since the beginning of last week's results from a few mega-cap technology players. W more_horizontal

Colgate-Palmolive's (CL) third-quarter 2023 organic sales advance 9% y/y, with improvements in the majority of divisions and categories. more_horizontal

The headline numbers for Colgate-Palmolive (CL) give insight into how the company performed in the quarter ended September 2023, but it may be worthwh more_horizontal

Colgate-Palmolive Company (NYSE:CL) posted a third-quarter earnings Friday that topped expectations due in part to price increases that upped margins. more_horizontal

Colgate-Palmolive (CL) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to more_horizontal

The consumer products company reports third-quarter adjusted earnings of 86 cents a share, while Wall Street called for 80 cents. more_horizontal